| |
| |
|
| Insider
Information: |
Milano Vincent |
| Relationship: |
Director |
| City: |
Exton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
78,847 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$404,914 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
78,847 |
|
|
| Total
Value |
$404,914 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
4
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 14.6%
|
 -141.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Verticalnet Inc |
VERT |
Director |
2008-01-25 |
0 |
2005-01-20 |
0 |
Premium* |
|
|
Viropharma Inc |
VPHM |
President and CEO, Dir... |
2014-01-24 |
0 |
2005-12-13 |
0 |
Premium* |
|
|
Aceragen, Inc |
ACGN |
|
2023-08-10 |
8,987 |
2014-12-12 |
0 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
Director |
2018-06-13 |
10,000 |
2017-06-15 |
0 |
Premium* |
|
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2018-05-31 |
0 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2024-02-29 |
51,997 |
2021-11-24 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
Director |
2023-06-02 |
7,863 |
2022-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VERT |
Verticalnet Inc |
Director |
– • – |
2005-01-20 |
4 |
A |
$0.01 |
$74 |
D/D |
7,407 |
7,407 |
|
- |
|
| VPHM |
Viropharma Inc |
officerTitle |
• – – |
2005-12-13 |
4 |
OE |
$0.99 |
$59,399 |
D/D |
59,999 |
95,697 |
|
- |
|
| VPHM |
Viropharma Inc |
officerTitle |
• – – |
2005-12-13 |
4 |
S |
$19.82 |
$1,188,994 |
D/D |
(59,999) |
35,698 |
|
- |
|
| VPHM |
Viropharma Inc |
officerTitle |
• – – |
2005-12-20 |
4 |
OE |
$2.16 |
$177,687 |
D/D |
21,244 |
56,942 |
|
- |
|
| VERT |
Verticalnet Inc |
Director |
– • – |
2006-02-14 |
4 |
A |
$0.01 |
$141 |
D/D |
14,085 |
21,492 |
|
- |
|
| VPHM |
Viropharma Inc |
VP, COO & CFO |
• – – |
2007-08-16 |
4 |
B |
$8.04 |
$32,638 |
D/D |
4,000 |
60,942 |
2.74 |
- |
|
| VERT |
Verticalnet Inc |
Director |
– • – |
2008-01-25 |
4 |
D |
$2.56 |
$983 |
D/D |
(384) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2009-01-09 |
4 |
OE |
$11.63 |
$261,563 |
D/D |
22,500 |
83,442 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2009-01-09 |
4 |
D |
$13.50 |
$261,563 |
D/D |
(19,375) |
64,067 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2009-02-27 |
4 |
S |
$4.01 |
$9,569 |
D/D |
(2,300) |
66,367 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2010-12-13 |
4 |
D |
$16.89 |
$105,934 |
D/D |
(6,272) |
64,390 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2010-12-13 |
4 |
OE |
$14.13 |
$141,250 |
D/D |
10,000 |
74,390 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2011-11-21 |
4 |
AS |
$22.53 |
$1,727,444 |
D/D |
(76,687) |
76,208 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2011-11-21 |
4 |
OE |
$2.09 |
$257,937 |
D/D |
76,687 |
117,899 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2011-12-05 |
4 |
OE |
$0.99 |
$31,367 |
D/D |
15,005 |
91,213 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2012-11-08 |
4 |
OE |
$3.14 |
$378,273 |
D/D |
83,418 |
135,834 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2012-11-08 |
4 |
S |
$24.54 |
$2,047,328 |
D/D |
(83,418) |
94,416 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2012-11-28 |
4 |
OE |
$3.55 |
$63,900 |
D/D |
18,000 |
112,416 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2013-12-18 |
4 |
OE |
$5.91 |
$6,317,885 |
D/D |
586,310 |
393,579 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2013-12-18 |
4 |
D |
$49.74 |
$16,802,669 |
D/D |
(337,810) |
362,846 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2014-01-06 |
4 |
OE |
$3.55 |
$143,097 |
D/D |
40,309 |
403,155 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2014-01-17 |
4 |
OE |
$3.14 |
$686,213 |
D/D |
79,126 |
482,281 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2014-01-24 |
4 |
D |
$50.00 |
$24,114,050 |
D/D |
(482,281) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2014-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
311,798 |
311,798 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2014-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(311,798) |
0 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
